Health Care·Health Care Equipment·$158.4B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.19 | N/A | +0.00% |
management commentary, guidance changes, and full analysis available with Pro.
| +0.00% |
Tone: Neutral
Overall, management expressed a steady outlook but acknowledged some market pressures. There was no significant change in their strategic direction.
Management highlighted stability in core product lines.
They noted ongoing challenges in certain market segments.
Abbott Labs reported earnings that met expectations for EPS, but the stock fell by 2.83% following the announcement. The decline may reflect investor concerns about market challenges and the lack of new guidance. Overall, the company seems to be maintaining stability, but uncertainty remains in certain areas.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
BANK HAWAII CORP
Jan 22, 2024